Kim D.

Kim D. is an experienced professional in clinical operations, currently serving as Director of Clinical Operations at BridgeBio since December 2023. Prior roles include Senior Director and Head of Clinical Operations at Arcellx, as well as various positions at BridgeBio where responsibilities involved supporting subsidiaries. Kim D.'s background includes significant experience at Corcept Therapeutics as Senior Clinical Trial Manager, leading multiple Phase 1/2 studies, and prior roles at Pharmacyclics focusing on Phase 1/2 protocols for Multiple Myeloma. Kim D.'s career began with positions at Codexis, Nektar Therapeutics, Genentech, and Bayhill Therapeutics, complemented by a degree in Biological Sciences from California Polytechnic State University-San Luis Obispo and a certification in Clinical Research Conduct and Management from UC Berkeley Extension.